- Home
- GROW vs RVPH Comparison
GROW vs RVPH Comparison
Compare GROW & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- RVPH
- Stock Information
- Founded
- GROW 1968
- RVPH 2006
- Country
- GROW United States
- RVPH United States
- Employees
- GROW N/A
- RVPH N/A
- Industry
- GROW Investment Managers
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- RVPH Health Care
- Exchange
- GROW Nasdaq
- RVPH Nasdaq
- Market Cap
- GROW 34.9M
- RVPH 37.1M
- IPO Year
- GROW N/A
- RVPH N/A
- Fundamental
- Price
- GROW $2.43
- RVPH $1.50
- Analyst Decision
- GROW
- RVPH Strong Buy
- Analyst Count
- GROW 0
- RVPH 5
- Target Price
- GROW N/A
- RVPH $14.50
- AVG Volume (30 Days)
- GROW 40.5K
- RVPH 242.1K
- Earning Date
- GROW 12-12-2024
- RVPH 11-12-2024
- Dividend Yield
- GROW 3.67%
- RVPH N/A
- EPS Growth
- GROW N/A
- RVPH N/A
- EPS
- GROW 0.09
- RVPH N/A
- Revenue
- GROW $10,984,000.00
- RVPH N/A
- Revenue This Year
- GROW N/A
- RVPH N/A
- Revenue Next Year
- GROW N/A
- RVPH N/A
- P/E Ratio
- GROW $27.33
- RVPH N/A
- Revenue Growth
- GROW N/A
- RVPH N/A
- 52 Week Low
- GROW $2.38
- RVPH $0.60
- 52 Week High
- GROW $3.11
- RVPH $6.80
- Technical
- Relative Strength Index (RSI)
- GROW 35.11
- RVPH 66.56
- Support Level
- GROW $2.38
- RVPH $1.15
- Resistance Level
- GROW $2.52
- RVPH $1.25
- Average True Range (ATR)
- GROW 0.06
- RVPH 0.12
- MACD
- GROW -0.00
- RVPH 0.02
- Stochastic Oscillator
- GROW 25.00
- RVPH 92.31
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.